Device makers divulge doc payments

Ever wonder how much orthopedic device makers are shelling out to so-called consultants? You're in luck. The five big implant companies have posted the figures to their websites. And the big news is that 47 docs or hospitals netted more than $1 million each. Almost half of them--21 to be exact--got their big checks from Zimmer Holdings. Massachusetts General Hospital netted a whopping $8.67 million.

The other companies that disclosed the info are Stryker, Johnson & Johnson subsidiary DePuy, Smith & Nephew, and Biomet. They did so under a deal with the U.S. Justice Department, which had been investigating financial relationships between the companies and surgeons. And these four handed out some big bucks, too; J&J's largest payment was around $6.75 million, and Stryker's was about $3.05 million.

- read Stryker's payment disclosure here
- read Smith & Nephew's disclosure here
- see Biomet's list
- read the report from CNN Money

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.